In conclusion, the present study showed that AQ1 G4-binding compound inhibited KIT expression and its downstream signaling molecules GRB2, AKT and FYN in two in vitro models of human and canine mast cell neoplasms (HMC1.2 and C2 cells). The gene discussed is FYN; the disease is mast cell neoplasm.